Overview

Variability in Adrenergic Response

Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
The goal of this project is to determine the genetic factors contributing to interindividual differences in response to physiological and pharmacological vasoconstrictors and vasodilators.
Phase:
N/A
Details
Lead Sponsor:
Vanderbilt University
Vanderbilt University Medical Center
Collaborators:
National Center for Research Resources (NCRR)
National Heart, Lung, and Blood Institute (NHLBI)
Treatments:
Adrenergic Agents
Nitroglycerin
Oxymetazoline
Phenylephrine